BG103881A - Method for the preparation of elurbiprophene pastills - Google Patents

Method for the preparation of elurbiprophene pastills

Info

Publication number
BG103881A
BG103881A BG103881A BG10388199A BG103881A BG 103881 A BG103881 A BG 103881A BG 103881 A BG103881 A BG 103881A BG 10388199 A BG10388199 A BG 10388199A BG 103881 A BG103881 A BG 103881A
Authority
BG
Bulgaria
Prior art keywords
pastills
preparation
mixture
elurbiprophene
pastill
Prior art date
Application number
BG103881A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Day
Huw Jones
Carl Smith
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of BG103881A publication Critical patent/BG103881A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG103881A 1997-05-22 1999-11-15 Method for the preparation of elurbiprophene pastills BG103881A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (1)

Publication Number Publication Date
BG103881A true BG103881A (en) 2000-05-31

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103881A BG103881A (en) 1997-05-22 1999-11-15 Method for the preparation of elurbiprophene pastills

Country Status (31)

Country Link
US (1) US6194003B1 (cs)
EP (1) EP0983059B1 (cs)
JP (1) JP2001527567A (cs)
KR (1) KR20010012739A (cs)
CN (1) CN1154480C (cs)
AR (1) AR015812A1 (cs)
AT (1) ATE245021T1 (cs)
AU (1) AU725760B2 (cs)
BG (1) BG103881A (cs)
BR (1) BR9809651A (cs)
CA (1) CA2290830C (cs)
CZ (1) CZ290816B6 (cs)
DE (1) DE69816440T2 (cs)
DK (1) DK0983059T3 (cs)
ES (1) ES2202871T3 (cs)
GB (1) GB9710521D0 (cs)
HU (1) HU224954B1 (cs)
ID (1) ID22949A (cs)
IL (1) IL132999A0 (cs)
IN (1) IN187837B (cs)
MY (1) MY118410A (cs)
NO (1) NO995681L (cs)
NZ (1) NZ500664A (cs)
PL (1) PL190947B1 (cs)
PT (1) PT983059E (cs)
RU (1) RU2203046C2 (cs)
SK (1) SK283701B6 (cs)
TR (1) TR199902725T2 (cs)
UA (1) UA53714C2 (cs)
WO (1) WO1998052539A1 (cs)
ZA (1) ZA984260B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1235558T3 (da) 1999-12-09 2006-10-09 Reckitt Benckiser Healthcare Sammenpresset tabletsammensætning, der omfatter et NSAID
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
EP1651195A4 (en) * 2003-07-11 2007-10-03 Myriad Genetics Inc PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US8808735B2 (en) 2005-02-03 2014-08-19 Takeda Nycomed As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
US20070042034A1 (en) * 2005-07-22 2007-02-22 Myriad Genetics, Incorporated High drug load formulations and dosage forms
JP2009514857A (ja) * 2005-11-02 2009-04-09 テイコク ファーマ ユーエスエー インコーポレーテッド 感覚器官的に許容されるイブプロフェン経口投与用製剤、該製剤の製法並びに使用法
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
EA200901188A1 (ru) * 2007-07-23 2010-04-30 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Органолептически приемлемые дозированные лекарственные формы индольных агонистов серотониновых рецепторов для перорального применения и способы их применения
WO2010020772A2 (en) * 2008-08-22 2010-02-25 Reckitt Benckiser Healthcare (Uk) Limited Improvements in or relating to compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
RS55372B1 (sr) 2011-04-29 2017-03-31 Moberg Pharma Ab Farmaceutske kompozicije koje sadrže lokalni anestetik kao što je bupivakain, za lokalnu administraciju u ustima ili grlu
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
JP6315741B2 (ja) * 2015-08-18 2018-04-25 合同会社Ｐｈａｒｍａ Ｓｅｅｄｓ Ｃｒｅａｔｅ ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
ATE245021T1 (de) 2003-08-15
IN187837B (cs) 2002-06-29
SK158899A3 (en) 2000-05-16
AU7916598A (en) 1998-12-11
MY118410A (en) 2004-10-30
NZ500664A (en) 2001-01-26
UA53714C2 (uk) 2003-02-17
US6194003B1 (en) 2001-02-27
HUP0002121A3 (en) 2001-04-28
CZ290816B6 (cs) 2002-10-16
SK283701B6 (sk) 2003-12-02
HUP0002121A2 (hu) 2000-12-28
TR199902725T2 (xx) 2000-02-21
BR9809651A (pt) 2000-07-11
EP0983059B1 (en) 2003-07-16
PT983059E (pt) 2003-11-28
KR20010012739A (ko) 2001-02-26
CN1255848A (zh) 2000-06-07
PL190947B1 (pl) 2006-02-28
EP0983059A1 (en) 2000-03-08
PL336624A1 (en) 2000-07-03
WO1998052539A1 (en) 1998-11-26
IL132999A0 (en) 2001-03-19
JP2001527567A (ja) 2001-12-25
ES2202871T3 (es) 2004-04-01
CN1154480C (zh) 2004-06-23
AR015812A1 (es) 2001-05-30
DE69816440D1 (de) 2003-08-21
AU725760B2 (en) 2000-10-19
DK0983059T3 (da) 2003-11-03
CA2290830C (en) 2006-07-11
ZA984260B (en) 1999-02-20
GB9710521D0 (en) 1997-07-16
CZ412099A3 (cs) 2000-02-16
HU224954B1 (en) 2006-04-28
RU2203046C2 (ru) 2003-04-27
NO995681D0 (no) 1999-11-19
DE69816440T2 (de) 2004-05-13
CA2290830A1 (en) 1998-11-26
NO995681L (no) 1999-11-19
ID22949A (id) 1999-12-16

Similar Documents

Publication Publication Date Title
BG103881A (en) Method for the preparation of elurbiprophene pastills
EP0904781A3 (en) Improved pharmaceutical composition comprising fenofibrate
DE69216642D1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
CA2335179A1 (en) Tablet and process for making the same
ATE145131T1 (de) Ueberzogene zusammensetzung sowie verfahren zu ihrer herstellung
HUT43637A (en) Process for producing biologically active new materials and veterinary compositions containing them as active agents, and nematocide insecticide and acaricide compositions containing the above mentioned materials as active agents
ES8602599A1 (es) Un procedimiento de preparar un derivado de trans-1,2-diaminoxiclohexil-amida.
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
IL112957A0 (en) Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them
HUT40918A (en) Process for producing new galenic compositions with retard dissolution of the active agents
HUT38897A (en) Process for producing pharmaceutically active substituted benzamides and pharmaceutical compositions containing them as active agents
IE870112L (en) Fused benzazepines and intermediates thereof
IT8421821V0 (it) Struttura di blocco di iniezione per l'alimentazione di stampi con materiale termoplatisco fuso.
HUP0004588A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them
AU7095687A (en) Pellet-containing pharmaceutical compositions
EP0126651A3 (en) 2,4-dihydro-5-((substituted)phenyl)-4,4-disubstituted-3h-pyrazol-3-ones, 2,4-dihydro-5-((substituted)phenyl)-4, 4-disubstituted-3h-pyrazol-3-thiones, and a process for producing the same
TW350773B (en) Melted granulated preparation of sucralfate for the treatment of digestic ulcer and its manufacturing method thereof
AU2157099A (en) Processes for the production of man-made vitreous fibres
IE56229B1 (en) 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them
DE3265210D1 (en) Novel compounds with antiinflammatory and analgesic activity, process for the preparation thereof and pharmaceutical compositions therefrom
GR3001800T3 (en) 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivative, process for the production thereof, pharmaceutical composition and intermediates
IL86031A (en) Substituted thiophene compounds,their production and pharmaceutical compositions containing them
GR3034549T3 (en) Anhydrous composition comprising lactulose
HUT40648A (en) Process for producing optically active substituted 1,4-dihydro-pyridines and pharmaceutical compositions containing them as active agents
IL74388A (en) 2,3,4,5-tetrahydro-11-phenyl-1h-(1,4)diazepino(1,7-a)indoles,their production and pharmaceutical compositions containing them